First thoughts and preliminary insights into OpenAI’s GPT o1 Strawberry in the medical domain, with some expected and unexpected findings. We have a \.
Year 2023 face_with_colon_three
Mice overexpressing Has2 from the naked mole-rat showed an increase in hyaluronan levels in several tissues, and a lower incidence of spontaneous and induced cancer, attenuated inflammation through several pathways, extended lifespan and improved healthspan.
A Sept. 17 Georgetown University Medical Center (GUMC) seminar highlighted research on a revolutionary approach to cancer treatment: utilizing the body’s natural immune system to combat tumor growth rather than directly targeting cancer cells.
Alejandro Villagra, an associate professor in the department of oncology at the Georgetown University School of Medicine (GUSOM), shared his research in a talk hosted by the department of microbiology and immunology. The lecture focused on Villagra’s research on the manipulation of macrophages, a type of white blood cell active in the immune system, to combat the growth of cancerous tumors.
“Some people assume cancer research is about killing cancer directly,” Villagra told The Hoya. “We are focusing on the mechanisms we already have in order to kill cancer. So, these treatments, rather than the normal conception of killing the tumor, helps galvanize the immune system to indirectly kill cancer.”
Compiling this list to help myself and others learn about the entrepreneurial landscape and find opportunities for funding! My list includes brief descriptions/explanations for each entry. Many (but not all) of these resources are aimed at academic researchers seeking to spin off companies based on new biotechnology inventions.
Year 2022 Solar powered mitochondria could enable humans to use light to recharge their mitochondria and extend life also their bodies would be recharged by fuel from the sun.
Using light to optogenetically power mitochondria, this study shows that opposing the age-related decline in mitochondrial membrane potential leads to increased healthspan and lifespan in Caenorhabditis elegans. This result points to mitochondrial charge as a fundamental regulator of biological aging.
The group of Jürgen Knoblich at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences, has developed a new method that allows scientists to cultivate brain organoids with distinct cortical areas and front-to-back patterning.
Together with collaborators at the Human Technopole and the University of Milan-Bicocca, they report a method that gives scientists a deeper look into human-specific brain development and disorders. The study was published in Nature Methods on September 18.
Brain organoids are extensively used to study human brain development. Derived from human pluripotent stem cells, the 3D models allow scientists to study unique properties of the human brain. Researchers use cortical organoids to answer fundamental questions such as how the human brain can grow to its large size or how the human brain’s long-range connections form.
Single-cell profiling in the human cortex reveals aging-associated transcriptomic changes across all brain cell types, which overlap with effects with Alzheimer’s disease and show a convergent signature with psychopathology across multiple cell types.
One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.
Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over two weeks could help overcome a part of that challenge by generating larger quantities of neutralizing antibodies.
However, a fast multidose vaccine regimen is not practical for mass vaccination campaigns.
While current treatments for ailments related to aging and diseases like type 2 diabetes, Alzheimer’s, and Parkinson’s focus on managing symptoms, Texas A&M researchers have taken a new approach to fight the battle at the source: recharging mitochondrial power through nanotechnology.
Led by Dr…
When we need to recharge, we might take a vacation or relax at the spa. But what if we could recharge at the cellular level, fighting against aging and disease with the microscopic building blocks that make up the human body?
When we need to recharge, we might take a vacation or relax at the spa. But what if we could recharge at the cellular level, fighting against aging and disease with the microscopic building blocks that make up the human body?
The ability to recharge cells diminishes as humans age or face diseases. Mitochondria, often called the powerhouse of the cell, are central to energy production. When mitochondrial function declines, it leads to fatigue, tissue degeneration, and accelerated aging. Activities that once required minimal recovery now take far longer, highlighting the role that these organelles play in maintaining vitality and overall health.
While current treatments for ailments related to aging and diseases like type 2 diabetes, Alzheimer’s, and Parkinson’s focus on managing symptoms, Texas A&M researchers have taken a new approach to fight the battle at the source: recharging mitochondrial power through nanotechnology.
